Article Versions Notes

de Nonneville A, Barbolosi D, Andriantsoa M, El-Cheikh R, Duffaud F, Bertucci F, Salas S. Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin. Cancers. 2019; 11(3):432. https://doi.org/10.3390/cancers11030432

de Nonneville, Alexandre, Dominique Barbolosi, Maeva Andriantsoa, Raouf El-Cheikh, Florence Duffaud, François Bertucci, and Sebastien Salas. 2019. "Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin" Cancers 11, no. 3: 432. https://doi.org/10.3390/cancers11030432

de Nonneville, A., Barbolosi, D., Andriantsoa, M., El-Cheikh, R., Duffaud, F., Bertucci, F., & Salas, S. (2019). Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin. Cancers, 11(3), 432. https://doi.org/10.3390/cancers11030432